Management of chronic rhinosinusitis with steroid nasal irrigations: a viable non ‐surgical alternative in the COVID‐19 Era
ConclusionsAfter a trial of NSI, 64.4% of patients with CRS no longer met candidacy for ESS and had a significant improvement in SNOT ‐22 scores. This supports the use of nasal steroid irrigations in the medical management of CRS with and without surgical intervention and with and without nasal polyposis.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Auddie M. Sweis,
Tran B. Locke,
Jennifer E. Douglas,
Theodore C. Lin,
Brian M. Sweis,
Alyssa M. Civantos,
David W. Kennedy Tags: LETTER TO THE EDITOR Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Mometasone | Nasonex | Polyps | Smokers | Statistics | Study